redditischurch
redditischurch t1_j3giwta wrote
Reply to comment by RphAnonymous in A randomized double-blind controlled trial found post-exposure prophylaxis with hydroxychloroquine (HCQ) was not advantageous for the prevention of COVID-19 in asymptomatic individuals with high risk for SARS-CoV-2 infection. The incidence of COVID-19 was similar in both the HCQ group and control. by glawgii
For clarity, you are a pharmacist? If yes, I didn't realize there was a second checkpoint other than interactions, multiple prescriptions for same substance, etc. You are free to say no when there is good rationale? Thanks for any detail you're willing to share.
redditischurch t1_j3glj9r wrote
Reply to comment by pumog in A randomized double-blind controlled trial found post-exposure prophylaxis with hydroxychloroquine (HCQ) was not advantageous for the prevention of COVID-19 in asymptomatic individuals with high risk for SARS-CoV-2 infection. The incidence of COVID-19 was similar in both the HCQ group and control. by glawgii
Interesting. This must vary state to state, country to country. My understanding is in Canada pharmacists can only deny if they think it will bring harm to the patient (interactions, mistaken dosage, etc.) but not because of personal values.